ClinVar Miner

Submissions for variant NM_000212.3(ITGB3):c.1261G>A (p.Val421Met)

dbSNP: rs2143112328
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Platelet Disorders Variant Curation Expert Panel, ClinGen RCV001580214 SCV001809847 uncertain significance Glanzmann thrombasthenia 2024-06-06 reviewed by expert panel curation The ITGB3 missense variant NM_000212.2:c.1261G>A replaces the valine residue with a methionine residue (p.Val421Met) and is absent from control population databases. This variant has been observed in heterozygosity in an individual with a phenotype specific for Glanzmann's thrombasthenia (GT) (GT-09, PMID: 16463284); history of bleeding and impaired aggregation to at least two agonists, but normal or only mildly reduced agglutination with ristocetin (PP4_Moderate). It was observed in heterozygosity in GT-09 (PMID: 16463284) in combination with ITGB3 variant c.428T>G (p.Leu143Trp), classified pathogenic by the PD-EP, confirmation of phasing was not reported (PM3_supporting). The highest population minor allele frequency in gnomAD v4.1.0 is 0.00002666 (2/75032 alleles) in the African/African American population, which is lower than the ClinGen PD VCEP threshold (<0.0001; PM2_Supporting). In silico tools predict the variant is damaging to protein function (REVEL score of 0.738; PP3). In summary, this variant is of uncertain significance and lacks sufficient evidence to be classified as pathogenic or benign for GT. GT-specific criteria applied: PP4_moderate, PP3, PM2_supporting, PM3_supporting.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.